Cargando…

A multidisciplinary approach to optimizing care of patients treated with alpelisib

PURPOSE: The oral, α-specific phosphatidylinositol-3-kinase (PI3Kα) inhibitor alpelisib is the first PI3K inhibitor approved for the treatment of advanced breast cancer. As alpelisib is a relatively new therapeutic option, specific guidance and a multidisciplinary approach are needed to provide opti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rugo, Hope S., Lacouture, Mario E., Goncalves, Marcus D., Masharani, Umesh, Aapro, Matti S., O'Shaughnessy, Joyce A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749445/ https://www.ncbi.nlm.nih.gov/pubmed/35016012 http://dx.doi.org/10.1016/j.breast.2021.12.016

Ejemplares similares

THU259 Alpelisib-induced Diabetic Ketoacidosis: Call For A Multidisciplinary Approach
por: Kalara, Niketa, et al.
Publicado: (2023)

Response of Brain Metastases From PIK3CA-Mutant Breast Cancer to Alpelisib
por: Batalini, Felipe, et al.
Publicado: (2020)

Diabetic Ketoacidosis With Alpelisib
por: Jeun, Rebecca, et al.
Publicado: (2021)

Alpelisib for breast cancer
Publicado: (2022)

A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting
por: Hesketh, Paul J., et al.
Publicado: (2015)

Alpelisib-Induced Diabetic Ketoacidosis
por: Espinosa, Luis Borges, et al.
Publicado: (2021)

Alpelisib-Induced Diabetic Ketoacidosis
por: Nguyen, Paul, et al.
Publicado: (2021)

Effectiveness of Alpelisib + Fulvestrant Compared with Real‐World Standard Treatment Among Patients with HR+, HER2–, PIK3CA‐Mutated Breast Cancer
por: Turner, Stuart, et al.
Publicado: (2021)

Ketoacidosis in a Patient with Type 2 Diabetes Requiring Alpelisib: Learnings and Observations Regarding Alpelisib Initiation and Rechallenge
por: Leung, Mova, et al.
Publicado: (2022)

MON-678 Worsening Diabetes Control in Breast Cancer Patients Treated with Alpelisib
por: Geier, Robert, et al.
Publicado: (2020)

Tumor lysis Syndrome in a Patient with Metastatic Breast Cancer Treated with Alpelisib
por: Handy, Caitlin, et al.
Publicado: (2021)

Treating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case Series
por: Blow, Tahj, et al.
Publicado: (2021)

Medulloblastoma: optimizing care with a multidisciplinary approach
por: Thomas, Alice, et al.
Publicado: (2019)

A decade of letrozole: FACE
por: O’Shaughnessy, Joyce
Publicado: (2007)

A decade of letrozole: FACE
por: O’Shaughnessy, Joyce
Publicado: (2008)

Treatment options for patients with HR+/HER2− advanced breast cancer during the COVID-19 pandemic: dose reduction of ribociclib does not diminish efficacy
por: O’Shaughnessy, Joyce
Publicado: (2020)

Alpelisib-Induced Diabetic Ketoacidosis- A Case Report
por: Rodriguez, Lisette Patricia, et al.
Publicado: (2021)

A Case of Diabetic Keto Acidosis From Alpelisib
por: Thumma, Soumya P, et al.
Publicado: (2021)

Alpelisib-Induced Hyperglycemia- A Small Case Series
por: Ekanayake, Preethika Subashini, et al.
Publicado: (2021)

Case report: Alpelisib-induced Stevens–Johnson syndrome
por: Kurian, Christine Jane, et al.
Publicado: (2022)

Bilateral Panuveitis and Exudative Retinal Detachments Associated with Alpelisib
por: Chong, Yu Jeat, et al.
Publicado: (2022)

Beyond Skin Rash: Alpelisib-Induced Anaphylactic Reactions
por: Schutte, Tim, et al.
Publicado: (2023)

Treating Alpelisib-Induced Hyperinsulinemia in Patients with Advanced Breast Cancer – A Real-Life Experience
por: Percik, Ruth, et al.
Publicado: (2023)

The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer
por: Tripathy, Debu, et al.
Publicado: (2014)

Takotsubo Syndrome: Optimizing Care with a Multidisciplinary Approach
por: Kinno, Ryuta, et al.
Publicado: (2021)

Sanfilippo Syndrome: Optimizing Care with a Multidisciplinary Approach
por: Cyske, Zuzanna, et al.
Publicado: (2022)

Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
por: Garneau, Alexandre P., et al.
Publicado: (2021)

Alpelisib-Induced Diabetic Ketoacidosis in a Non-diabetic Patient
por: Fugere, Tyler, et al.
Publicado: (2021)

RF07 | PSUN359 Alpelisib-induced Diabetic Ketoacidosis
por: Majumdar, Sachin, et al.
Publicado: (2022)

Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: a matching-adjusted indirect comparison
por: Rugo, Hope S., et al.
Publicado: (2023)

Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases
por: Aapro, Matti, et al.
Publicado: (2010)

Growth in CHARGE syndrome: optimizing care with a multidisciplinary approach
por: Dijk, Dieuwerke R, et al.
Publicado: (2019)

The hedgehog pathway in triple‐negative breast cancer
por: Habib, Joyce G., et al.
Publicado: (2016)

Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial
por: Cortés, Javier, et al.
Publicado: (2016)

A systematic review and meta-analysis of selected toxicity endpoints of alpelisib
por: Shields, Misty, et al.
Publicado: (2020)

Alpelisib-Induced Diabetic Ketoacidosis: A Case Report and Review of Literature
por: Carrillo, Maritza, et al.
Publicado: (2020)

Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma
por: Xu, Hongwei, et al.
Publicado: (2021)

Alpelisib-Induced Diabetic Ketoacidosis in a Patient With Metastatic Breast Cancer
por: Al Zeyoudi, Jawaher, et al.
Publicado: (2021)

Alpelisib-Induced Diabetes Mellitus: Case Report, Pharmacodynamics and Management Considerations
por: Pla Peris, Begoña, et al.
Publicado: (2022)

Alpelisib-Induced Diabetic Ketoacidosis in a Patient With Metastatic Breast Cancer
por: Abufaied, Mohamad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a34jigagv27ma9ds5sj74hnncc